Petrobras Rescued by China and Scandal News Alike
The bribery scandal surrounding Petrobras has plagued the company since last year. Now it looks like there is a new twist in this Brazilian soap opera.
All Work
Chris Lange
Does the Mylan Secondary Make Its Stock Cheap?
Mylan has announced that it will have a 35 million share secondary offering. At Tuesday's closing price of $59.35, the offering would be valued at $2.08 billion.
Biotechs Raising New Capital in Droves
With the biotech industry so hot, it seems like many of the smaller players are trying to bolster their balance sheets to get enough capital for their future product pipeline plans.
Analysts Massively Increasing Dyax Price Targets
So far, analysts have not backed off their bullish views of Dyax. In fact, many analysts boosted their price targets remarkably on the news.
Monsanto Light on Revenues, Looks Light Ahead
Monsanto reported disappointing fiscal second-quarter earnings before the U.S. markets opened Wednesday.
Why Dyax Will Dominate Biotech News on Wednesday
Dyax is almost certain to dominate the biotech news flow on Wednesday, after it announced positive trial data on Tuesday evening.
How Etsy IPO Terms Will Value It at $1.66 Billion
Etsy Inc. has made an amended filing with the Securities and Exchange Commission for the pricing of its initial public offering.
Ebola Finances Coming Back in the News
Within the past week, two Ebola-related companies are showing renewed optimism for their positions, whether it is securing a contract or raising capital.
What to Expect From Monsanto Earnings
Monsanto is scheduled to report its fiscal second-quarter financial results Wednesday before the opening bell.
Why Analyst Sees CIT Undervalued by Over 30%
If one were looking to invest in the financial sector at this time, then a value stock would be a solid bet. Oppenheimer thinks it has a strong pick.
Despite Caution, 3 Top Oil Stock Picks From Wells Fargo
Wells Fargo made some broad calls on the oil market about what it sees coming for West Texas Intermediate (WTI) crude, as well as for some major oil companies.
Why Merrill Lynch Loves CenturyLink and Its High-Yield Dividend
CenturyLink is making an interesting case for its dividend payout ratio for the coming years, and Merrill Lynch likes what it sees.
Will IBM Just Crowd the Internet of Things Space?
ThinkstockAs the Internet of Things (IoT) continues to grow, and more devices connect more people and information across the globe, many key technology companies have to find a way to profit from this or…
Can Urban Outfitters Keep Its Rally Alive?
The question that Urban Outfitters investors may be asking is whether the stock's recent momentum can continue.
Are Auspex Shareholders Getting Enough in the Buyout?
News broke Monday that Teva Pharmaceutical Industries will acquire Auspex Pharmaceuticals. Existing investors will be wondering if they are getting enough in this buyout.
Can Boston Scientific Keep Its Turnaround Gains Going?
Boston Scientific shares are up almost 50% in the past six months, and the stock has more than doubled from two years ago. The question is whether this turnaround can keep turning around.
Can Skyworks Keep Up Its Robust Stock Performance?
Analysts across the board are incredibly bullish on Skyworks Solutions, and the company is experiencing rapid earnings and revenue growth. Still, can Skyworks keep running ever higher?
Why This Analyst Is So Positive on Delta Air
The independent research firm Argus has decided to add Delta Air to its coverage universe with a relatively positive outlook.
Two Very Different Analyst Views Ahead of Micron Earnings
Merrill Lynch has maintained a very positive view on Micron Technology, despite slightly lower estimates, while Wells Fargo remains very cautious.
3 Key Earnings Reports to Watch in the Week Ahead
24/7 Wall St. has put together a preview of three of the larger companies reporting their quarterly results at the end of March and beginning of April.